Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,259,600 | 1,209,300 | 1,157,100 | 1,036,000 | 1,113,500 |
| Cost of Goods | 466,900 | 477,900 | 468,300 | 447,000 | 457,700 |
| Gross Profit | 792,700 | 731,400 | 688,800 | 589,000 | 655,800 |
| Operating Expenses | 470,600 | 489,800 | 476,500 | 455,300 | 467,600 |
| Operating Income | 323,000 | 242,500 | 212,600 | 133,700 | 188,900 |
| Other Income | 17,700 | 109,800 | 28,500 | 20,600 | 22,400 |
| Pre-tax Income | 340,700 | 352,300 | 241,100 | 154,300 | 211,300 |
| Income Tax | 73,400 | 68,500 | 61,300 | 48,900 | 59,600 |
| Net Income Continuous | 267,300 | 283,800 | 179,800 | 105,400 | 151,700 |
| Net Income | $267,300 | $283,800 | $179,800 | $105,400 | $151,700 |
| EPS Basic Total Ops | 0.68 | 0.73 | 0.46 | 0.27 | 0.38 |
| EPS Basic Continuous Ops | 0.69 | 0.73 | 0.46 | 0.27 | 0.39 |
| EPS Diluted Total Ops | 0.67 | 0.70 | 0.45 | 0.27 | 0.37 |
| EPS Diluted Continuous Ops | 0.67 | 0.70 | 0.44 | 0.26 | 0.37 |
| EPS Diluted Before Non-Recurring Items | 0.68 | 0.61 | 0.48 | 0.32 | 0.45 |
| EBITDA(a) | $388,200 | $306,100 | $275,600 | $193,700 | $246,700 |